Trazodone for Sleep Disturbance in Early Alcohol Recovery
Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind clinical trial comparing trazodone (Desyrel) and
placebo among sleep-disturbed, alcohol-dependent individuals shortly after discharge from an
inpatient detoxification program. Subjects will undergo a baseline assessment and random
assignment to trazodone or identical placebo for 12 weeks. All persons completing the alcohol
detoxification at Stanley Street Treatment and Resources (SSTAR) will be screened. (SSTAR of
Rhode Island provides detoxification services to non/underinsured persons of Rhode Island.)
Phase:
Phase 2
Details
Lead Sponsor:
Rhode Island Hospital
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)